DossierENTITY

Chai-3

Coverage of Chai-3 in the Nexus archive.

Earliest in view: Jun 5 · 13:50 UTCMost recent: Jun 5 · 13:50 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHJun 5 · 13:50 UTCQUARTZ
Pfizer is licensing an AI startup's drug discovery software to speed up antibody design
Pfizer is licensing an AI startup's drug discovery software to accelerate antibody design. The software's Chai-3 model doubles the antibody design success rate compared to its predecessor.